These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35778228)

  • 41. Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis.
    Langholm LL; Manon-Jensen T; Karsdal MA; Bendtsen F; Leeming DJ; Møller S
    Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1040-1048. PubMed ID: 30768435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cirrhosis of liver and portal vein thrombosis - a review article.
    Debnath CR; Debnath MR; Alam MM; Moshwan MM; Alam MJ; Rana MS; Biswas D; Mahmuduzzaman M; Tarafder AJ
    Mymensingh Med J; 2014 Jul; 23(3):606-8. PubMed ID: 25178622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated preoperative von Willebrand factor is associated with perioperative thrombosis in infants and neonates with congenital heart disease.
    Hunt R; Hoffman CM; Emani S; Trenor CC; Emani SM; Faraoni D; Kimchi-Sarfaty C; Ibla JC
    J Thromb Haemost; 2017 Dec; 15(12):2306-2316. PubMed ID: 28981194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Portal vein thrombosis in liver cirrhosis - the added value of contrast enhanced ultrasonography.
    Danila M; Sporea I; Popescu A; Șirli R
    Med Ultrason; 2016 Jun; 18(2):218-33. PubMed ID: 27239658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased platelet ratio in patients with decompensated cirrhosis indicates a higher risk of portal vein thrombosis.
    Zanetto A; Campello E; Burra P; Senzolo M; Simioni P
    Liver Int; 2023 Jan; 43(1):155-159. PubMed ID: 36156848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies.
    Ogren M; Bergqvist D; Björck M; Acosta S; Eriksson H; Sternby NH
    World J Gastroenterol; 2006 Apr; 12(13):2115-9. PubMed ID: 16610067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of portal system hemodynamics for the prediction of portal vein thrombosis in cirrhosis-A systematic review and meta-analysis.
    Giri S; Singh A; Kolhe K; Kozyk M; Roy A
    J Clin Ultrasound; 2023 Sep; 51(7):1248-1258. PubMed ID: 37459439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
    Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
    Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus.
    Driever EG; von Meijenfeldt FA; Adelmeijer J; de Haas RJ; van den Heuvel MC; Nagasami C; Weisel JW; Fondevila C; Porte RJ; Blasi A; Heaton N; Gregory S; Kane P; Bernal W; Zen Y; Lisman T
    Hepatology; 2022 Apr; 75(4):898-911. PubMed ID: 34559897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
    Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study.
    Nery F; Carneiro P; Correia S; Macedo C; Gandara J; Lopes V; Valadares D; Ferreira S; Oliveira J; Teixeira Gomes M; Miranda HP; Rautou PE; Valla D
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e108-e113. PubMed ID: 33208682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Portal vein thrombosis in liver cirrhosis.
    Fimognari FL; Violi F
    Intern Emerg Med; 2008 Sep; 3(3):213-8. PubMed ID: 18274708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis.
    Xing Y; Tian Z; Jiang Y; Guan G; Niu Q; Sun X; Han R; Jing X
    Ann Med; 2022 Dec; 54(1):302-309. PubMed ID: 35060835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis.
    Pan J; Wang L; Gao F; An Y; Yin Y; Guo X; Nery FG; Yoshida EM; Qi X
    Eur J Intern Med; 2022 Oct; 104():21-32. PubMed ID: 35688747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of surgical procedures on the occurrence and development of postoperative portal vein thrombosis in patients with cirrhosis complicated by portal hypertension.
    Sun L; Zhou H; Gu L; Jiang C; Liu Y; Xu Q
    Int J Surg; 2015 Apr; 16(Pt A):31-35. PubMed ID: 25701619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Portal vein thrombosis is associated with an increased risk of bone fractures.
    Gairing SJ; Galle PR; Schattenberg JM; Kostev K; Labenz C
    PLoS One; 2022; 17(4):e0267535. PubMed ID: 35452487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: A systematic review and meta-analysis.
    Xian J; Tang Y; Shao H; Wang X; Zhang M; Xing T
    Medicine (Baltimore); 2021 Apr; 100(16):e25439. PubMed ID: 33879676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
    Hayashi T; Takatori H; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Kitamura K; Kawaguchi K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Toyama T; Okumura K; Kozaka K; Kaneko S
    BMC Gastroenterol; 2019 Dec; 19(1):217. PubMed ID: 31842768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis.
    Kukla M; Waluga M; Żorniak M; Berdowska A; Wosiewicz P; Sawczyn T; Bułdak RJ; Ochman M; Ziora K; Krzemiński T; Hartleb M
    World J Gastroenterol; 2017 Apr; 23(14):2613-2624. PubMed ID: 28465646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients.
    Dalbeni A; Cattazzo F; De Marco L; Bevilacqua M; Zoncapè M; Lombardi R; Stupia R; Mantovani A; Sacerdoti D
    Dig Liver Dis; 2024 Mar; 56(3):477-483. PubMed ID: 37778894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.